Skip to main content
. 2022 Jan 22;14(3):554. doi: 10.3390/cancers14030554
EC Esophageal Cancer
EAC Esophageal Adenocarcinoma
ESCC Esophageal Squamous cell cancer
GC Gastric cancer
GEJC Gastroesophageal junction cancer
PD-1/PD-L1/2 Programmed-cell death 1/Programmed-cell death-ligand 1/2
CTLA-4 Cytotoxic T-lymphocyte-associated antigen 4
TME Tumor Micro-Environment
CPS Combined Positive Score
MSI Microsatellite Instability
MSS Microsatellite Stable
PFS Progression-free survival
DFS Disease-free survival
OS Overall Survival
dMMR Deficient MisMatch Repair
pCR Pathologic complete response